Speaker illustration

Professor Mauro Giacca

King's College London, London (United Kingdom of Great Britain & Northern Ireland)

Mauro Giacca, MD PhD, is Head of the School of Cardiovascular and Metabolic Medicine&Sciences at King’s College London. Until 2019, he has served as Director-General of the ICGEB, a United Nations organization. Since 2005, he is Full Professor of Molecular Biology at the University of Trieste, Italy. Prof Giacca is considered an expert in gene and RNA therapy for cardiovascular disorders. He leads a recently established MRC/BHF Centre for Cardiac Repair and Regeneration (REACT) and is Co-Director of the BHF Centre of Research Excellence at King’s. His research is funded internationally, including three consecutive ERC Advanced grants and 2 consecutive Leducq Foundation grants, and a BHF Programme grant. Prof Giacca is a Fellow of the Academy of Medical Sciences, UK and is the past-president of the International Society for Heart Research (ISHR)-ES. He is the founder of Forcefield Therapeutics and Heqet Therapeutics, which develop biologics for myocardial infarction and heart failure.

Vascular and immune control of organ function

Event: ESC Congress 2024

Topic: Ischaemia, Infarction, Cardioprotection

Session type: Symposium

Thumbnail

Basic and Translational Late-Breaking Science

Event: ESC Congress 2024

Topic: Basic Science

Session type: Late-Breaking Science

Thumbnail

Hot papers in genes and gene editing in heart failure

Event: ESC Congress 2023

Topic: Basic Science

Session type: Symposium

Thumbnail

RNA and gene therapy of vascular diseases

Event: ESC Congress 2022

Topic: Vascular Diseases

Session type: Moderated ePosters

Thumbnail

CRISPR/Cas9 gene editing for heart disease: ready for prime time?

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacology and Pharmacotherapy

Session type: Symposium

Thumbnail

Young Investigator Awards Session in Basic Science

Event: ESC Congress 2021 - The Digital Experience

Topic: Basic Science

Session type: Award Sessions

Thumbnail

The dynamic epigenome - Programming the cardiac myocyte in development, health and disease.

Event: Frontiers in CardioVascular Biology 2018

Topic: Cardiac Diseases

Session type: Featured Symposium

Thumbnail